Medicine & Life Sciences
4,17 beta-dihydroxy-4-androstene-3-one
14%
Actins
27%
Alternative Splicing
70%
AZD 6244
21%
AZD8186
73%
Breast Neoplasms
100%
cabozantinib
13%
Cell Line
41%
Cell Proliferation
12%
Cholangiocarcinoma
37%
Colorectal Neoplasms
25%
Combination Drug Therapy
36%
Cyclin E
13%
Decitabine
42%
Drug Therapy
44%
eribulin
27%
Everolimus
13%
Fibroblast Growth Factor Receptors
84%
Growth
26%
Heterografts
66%
Hormones
22%
Immunoblotting
11%
Immunoconjugates
43%
Immunohistochemistry
13%
Immunotherapy
28%
In Vitro Techniques
36%
Mitochondrial Genes
10%
Mitogen-Activated Protein Kinase Kinases
74%
Mitogen-Activated Protein Kinases
64%
Mutation
16%
N-(4-(3-chloro-4-(2-pyridinylmethoxy)anilino)-3-cyano-7-ethoxy-6-quinolyl)-4-(dimethylamino)-2-butenamide
56%
Neoplasms
78%
Oxidative Phosphorylation
36%
Paclitaxel
38%
palbociclib
30%
Phosphatidylinositol 3-Kinases
32%
Progression-Free Survival
15%
Protein Array Analysis
33%
Proto-Oncogene Proteins c-mdm2
10%
sacituzumab govitecan
50%
selinexor
60%
Therapeutics
23%
Thyroid Neoplasms
33%
Topoisomerase I Inhibitors
28%
trametinib
16%
Trastuzumab
38%
Triple Negative Breast Neoplasms
88%
Tumor Burden
12%
Up-Regulation
17%